[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100657402":3},{"organization":4,"outcomesModule":7,"designInfo":18,"detailedDescription":21,"studyPopulation":22,"armGroups":23,"interventions":29,"overallOfficials":17,"centralContacts":35,"locations":45,"responsibleParty":64,"collaborators":17,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":17,"eligibilityCriteria":72,"healthyVolunteers":68,"sex":73,"minAge":74,"maxAge":17,"enrollmentInfo":75,"targetDuration":17,"studyType":78,"phases":17,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":88,"whyStopped":17,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Olympus Corporation of the Americas","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":17,"otherOutcomes":17},[9,13],{"measure":10,"description":11,"timeFrame":12},"Safety Measure","Incidence of procedure-related adverse events (AEs), serious adverse events (SAEs), and device deficiencies occurring during standard-of-care procedures performed using the Modified SOLTIVE Laser System, including assessment of relatedness to the investigational data-collection components.","From enrollment to the resolution of the adverse event, assessed up to 30 days.",{"measure":14,"description":15,"timeFrame":16},"Feasibility Measure","Proportion of enrolled subjects with a complete and evaluable procedural dataset, defined as successful collection of SOLTIVE laser procedural data, spectral log data, and endoscopic procedural video data.","From procedural data collection to data entry, assessed up to 10 days.",null,{"allocation":17,"interventionModel":17,"interventionModelDescription":17,"primaryPurpose":17,"observationalModel":19,"timePerspective":20,"maskingInfo":17},"CASE_ONLY","PROSPECTIVE","This prospective, observational study is being conducted to collect real-world procedural data and visual recordings during routine standard of care (SOC) urology procedures. These data will be used to support the research and development of future algorithmic software for the SOLTIVE™ Laser System with features designed to recognize anatomical structures and procedural contexts.\n\nThe purpose of this study is limited to passive data acquisition and does not involve the clinical use of algorithmic decision support, modification of laser behavior, or changes to procedural technique or patient management. Patients undergoing SOC lithotripsy for bladder, ureter, and kidney calculi (colloquially called \"stones\") and patients undergoing soft tissue procedures for benign prostatic hyperplasia (BPH) will be considered for inclusion in the study.","The study will include adult patients diagnosed with urolithiasis, bladder, ureter, and kidney calculi, or benign prostatic hyperplasia who are scheduled to undergo laser treatment.",[24],{"label":25,"type":17,"description":26,"interventionNames":27},"Thulium Fiber Laser Procedure","Adult patients undergoing procedural laser treatment for urolithiasis, bladder, ureter, and kidney calculi, or benign prostatic hyperplasia.",[28],"Device: SOLTIVE Premium SuperPulsed Laser System",[30],{"type":31,"name":32,"description":33,"armGroupLabels":34,"otherNames":17},"DEVICE","SOLTIVE Premium SuperPulsed Laser System","The SOLTIVE™ Premium SuperPulsed Laser System is a thulium fiber laser (TFL) for lithotripsy and soft tissue ablation and enucleation procedures in the treatment of renal and urinary calculi and benign prostatic hyperplasia.",[25],[36,41],{"name":37,"role":38,"phone":39,"phoneExt":17,"email":40},"Amanda Meyer","CONTACT","314-303-9510","amanda.meyer@olympus.com",{"name":42,"role":38,"phone":43,"phoneExt":17,"email":44},"Sharon Rabine","479-644-7840","sharon.rabine@olympus.com",[46],{"facility":47,"status":17,"city":48,"state":49,"zip":50,"country":51,"countryCode":52,"cosmosGeoPoint":53,"geoPoint":58,"contacts":59},"University of Kansas Medical Center","Kansas City","Kansas","66160","United States","US",{"type":54,"coordinates":55},"Point",[56,57],-94.62746,39.11417,{"lat":57,"lon":56},[60],{"name":61,"role":38,"phone":62,"phoneExt":17,"email":63},"Jane Ledesma","913-588-8721","jledesma2@kumc.edu",{"type":65,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR","100657402","modified-soltive-study-100657402",false,"NCT07838077","Modified SOLTIVE Study","Real World Data Collection With an Investigational Device for Developing and Evaluating the Clinical Performance of Algorithms in Thulium Fiber Laser Procedures","Inclusion Criteria:\n\n1. Willing and able to provide informed consent\n2. ≥ 18 years of age\n3. The subject is presenting for the treatment of at least one of the following: a. Bladder, ureter, or kidney stones requiring endoscopic laser lithotripsy as determined by the Investigator b. BPH requiring surgical management with laser enucleation or vaporization of the prostate as determined by the Investigator c. Failed or unwilling to undergo medical (non-surgical) treatment of BPH\n\nExclusion Criteria:\n\n1. Concurrently participating in another competing clinical study\n2. Contraindicated for endoscopic laser lithotripsy as determined by the Investigator\n3. Subject is undergoing percutaneous nephrolithotomy (PCNL) or mini-PCNL\n4. Subject presents will bladder stone(s) only\n5. Subject presents with ureteral stricture disease or any anatomical abnormalities of the urinary system\n6. Subject presents an active infection of the urinary tract (UTI) or sepsis of any origin\n7. Subject is contraindicated for laser enucleation or ablation of the prostate as determined by the Investigator\n8. Subject presents with prostate glands ≥ 200 grams\n9. Subject is pregnant or breast feeding","ALL","18 Years",{"count":76,"type":77},250,"ESTIMATED","OBSERVATIONAL","This is a study to collect procedural data during the use of the SOLTIVE™ Premium SuperPulsed Laser System in the treatment of bladder, ureteral, and kidney stones and BPH to inform the development of software algorithms.",[81,82,83],"Calculi, Renal","Calculi, Urinary","Benign Prostatic Hyperplasia",[85,86,83,87],"Renal Calculi","Urinary Calculi","SOLTIVE SuperPulsed Laser System","NOT_YET_RECRUITING","2026-09-30",{"date":91,"type":92},"2026-10-05","ACTUAL",{"date":94,"type":77},"2026-11",{"date":96,"type":77},"2028-05",{"name":5,"class":6},1]